ANI Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.926; its P/E ratio is 71.36; ANI Pharmaceuticals is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $0.99. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	$ 131.83M	$ 116.55M	$ 106.79M	$ 94.23M
Gross Profit	-	$ 83.73M	$ 74.26M	$ 69.08M	$ 57.91M
EBIT	-	$ 17.91M	$ 12.40M	$ 9.86M	$ 1.78M
EBITDA	-	$ 33.12M	$ 27.09M	$ 24.56M	-
Net Income Common Stockholders	-	$ 9.53M	$ 5.84M	$ 1.03M	$ -5.06M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 221.12M	$ 193.08M	$ 161.71M	$ 67.76M	$ 48.23M
Total Assets	$ 904.42M	$ 889.91M	$ 859.34M	$ 765.22M	$ 760.09M
Total Debt	$ 285.67M	$ 285.88M	$ 286.09M	$ 286.31M	$ 286.52M
Net Debt	$ 64.55M	$ 92.80M	$ 124.39M	$ 218.55M	$ 238.29M
Total Liabilities	$ 446.82M	$ 435.20M	$ 424.87M	$ 425.74M	$ 421.55M
Stockholders Equity	$ 457.60M	$ 454.71M	$ 434.47M	$ 339.48M	$ 338.54M
Cash Flow	-
Free Cash Flow	-	$ 27.62M	$ 13.80M	$ 19.07M	$ -7.54M
Operating Cash Flow	-	$ 32.17M	$ 20.63M	$ 21.42M	$ -4.40M
Investing Cash Flow	-	$ -4.55M	$ -6.83M	$ -2.35M	$ -3.14M
Financing Cash Flow	-	$ 3.75M	$ 80.15M	$ -4.55M	$ -508.00K

Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

Income Statement >

ANI Pharmaceuticals Debt to Assets

Balance Sheet >

ANI Pharmaceuticals Cash Flow

Cash Flow >

ANI Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing